Coherus Oncology (CHRS) Other Accumulated Expenses (2013 - 2026)
Coherus Oncology (CHRS) posted Other Accumulated Expenses of $11.27 million for Q2 2026, up 66.2% from $6.78 million a year earlier and up 3.6% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology's Other Accumulated Expenses came in at $11.25 million, down 43.8% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- In prior years, Coherus Oncology's Other Accumulated Expenses was $20.03 million in FY2024 (-52.3%), $42.03 million in FY2023 (+295.3%), $10.63 million in FY2022 (+204.5%) and $3.49 million in FY2021 (-71.3%).
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses since Q1 2025.
- On a year-over-year basis, Other Accumulated Expenses increased in 1 of the last eight quarters, with an average decline of 32.5%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2023, with growth of 295.3%; the weakest was Q4 2021, with a decline of 71.3%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $10.88 million (Q1 2026), $11.25 million (Q4 2025) and $7.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Coherus Oncology | 119.30 Mn | -516.84 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.27 Mn |
| Mar 31, 2026 | 10.88 Mn |
| Dec 31, 2025 | 11.25 Mn |
| Sep 30, 2025 | 7.10 Mn |
| Jun 30, 2025 | 6.78 Mn |
| Mar 31, 2025 | 11.45 Mn |
| Dec 31, 2024 | 20.03 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Jun 30, 2024 | 14.59 Mn |
| Mar 31, 2024 | 35.34 Mn |
| Dec 31, 2023 | 42.03 Mn |
| Sep 30, 2023 | 30.56 Mn |
| Jun 30, 2023 | 13.19 Mn |
| Mar 31, 2023 | 14.46 Mn |
| Dec 31, 2022 | 10.63 Mn |
| Sep 30, 2022 | 12.83 Mn |
| Jun 30, 2022 | 11.00 Mn |
| Mar 31, 2022 | 12.17 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 9.87 Mn |
API Access
Coherus Oncology Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();